These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 870271)

  • 21. [Serum concentration of digoxin in patients with congestive heart failure after intravenous furosemide].
    Ge H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):255-6. PubMed ID: 6544206
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-interaction between nifedipine and digoxin.
    Pedersen KE; Madsen JL; Klitgaard NA; Kjoer K; Hvidt S
    Dan Med Bull; 1986 Apr; 33(2):109-10. PubMed ID: 3709238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Furosemide and urinary digoxin clearance.
    Sempler P; Tilstone WJ; Lawson DH
    N Engl J Med; 1975 Sep; 293(12):612-3. PubMed ID: 1152903
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of alprazolam on digoxin kinetics and creatinine clearance.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B
    Clin Pharmacol Ther; 1985 Nov; 38(5):595-8. PubMed ID: 2865030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy.
    Finch MB; Johnston GD; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1984 Mar; 17(3):353-5. PubMed ID: 6712868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of volume expansion and furosemide diuresis on the renal clearance of digoxin.
    Gibson TP; Quintanilla AP
    J Pharmacol Exp Ther; 1981 Oct; 219(1):54-9. PubMed ID: 6793714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of propafenone on the pharmacokinetics of digoxin administered orally: a study in healthy volunteers].
    Cardaioli P; Compostella L; De Domenico R; Papalia D; Zeppellini R; Libardoni M; Pulido E; Cucchini F
    G Ital Cardiol; 1986 Mar; 16(3):237-40. PubMed ID: 3732716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased bioavailability of digoxin due to antacids and kaolin-pectin.
    Brown DD; Juhl RP
    N Engl J Med; 1976 Nov; 295(19):1034-7. PubMed ID: 972657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist.
    Denker AE; Morelli G; Vessey LK; Li S; Yuan J; Dunbar S; Lewis NM; Taggart W; Wagner JA
    Adv Ther; 2009 Feb; 26(2):230-40. PubMed ID: 19219408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal muscle binding and renal excretion of digoxin in man.
    Schenck-Gustafsson K; Jogestrand T; Dahlqvist R
    Eur J Clin Pharmacol; 1987; 31(5):601-3. PubMed ID: 3830246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses.
    Rabkin SW; Grupp G
    Acta Cardiol; 1975; 30(5):343-51. PubMed ID: 1082700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furosemide-induced forced diuresis in digoxin intoxication.
    Rotmensch HH; Graff E; Terdiman R; Aviram A; Ayzenberg O; Laniado S
    Arch Intern Med; 1978 Oct; 138(10):1495-7. PubMed ID: 708170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators].
    Markiewicz K; Dryjański T; Cholewa M; Gawor Z
    Kardiol Pol; 1990 Feb; 33(2):107-15. PubMed ID: 2277481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary excretion studies with digoxin in man.
    Klotz U; Antonin KH
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):332-4. PubMed ID: 892949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two different loading doses of digoxin in severe renal impairment.
    Ohnhaus EE; Lenzinger HR; Galeazzi RL
    Eur J Clin Pharmacol; 1980 Nov; 18(6):467-72. PubMed ID: 7461014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of digoxin on plasma renin activity in hypertensive patients.
    Montanaro D; Antonello A; Baggio B; Finotti P; Melacini P; Ferrari M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):322-3. PubMed ID: 7000718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of methodology in single-dose studies of digoxin bioavailability.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Pharmacology; 1976; 14(2):182-90. PubMed ID: 959319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
    Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.